POSB72 Subcutaneous Daratumumab in the Treatment of Multiple Myeloma in Italy: A Budget Impact Analysis

Abstract

Authors

G Ghetti L Pradelli E Crovato S Bellucci

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×